Atrial fibrillation and dialysis. A convergence of risk factors;Fibrilación auricular y diálisis. Confluencia de factores

Revista Espanola de Cardiologia

Volumn 59, Issue 8, 2006, Pages 766-769

  Grande, Ángel ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

CARDIOVERSION; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

EID: 33749601691     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091879     Document Type: Article

References (25)

1. Ceballos M, López-Revuelta K, Caracho R, García López F, Castro P, Gutiérrez JA, et al. Informe de diálisis y trasplante año 2001 de la Sociedad Española de Nefrología y Registros autonómicos. Nefrología. 2005;24:21-33.
2. Branwuald E. Cardiovascular medicine at the turn of the millenium: triumphs, concerns and apportunities. N Engl J Med. 1997;337:1360-69.
3. Tsang TS, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol. 2003;42:93-100.
4. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. The ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852-1923.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med. 2004;351:1296-305.
6. Caramelo C, Gil P. Insuficiencia combinada cardiorrenal: una clave evolutiva y terapéutica en el fallo cardíaco. Rev Esp Cardiol. 2006;59:87-90.
7. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm L, et al. Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154-69.
8. Vázquez E, Sánchez C, Lozano C, García MJ, Guzmán M, Borrego F, et al. Incidencia de la fibrilación auricular en los pacientes en hemodiálisis. Estudio prospectivo a largo plazo. Rev Esp Cardiol. 2006;59:779-84.
9. Kannel WB, Abbot RD, Savage D, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med. 1982;306:1018-22.
10. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol. 2003;4:1-10.
11. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail. 2001;23:71-6.
12. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dualysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995;47:884-90.
13. Tezcan UK, Amasyali B, Can I, Aytemir K, Kose S, Yavuz I, et al. Increased P wave dispersion and maximum P wave duration after hemodialysis. Ann Noninvasive Electrocardiol. 2004;9:34-8.
14. Korzets A, Ori Y, Herman M. Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant. 2001;16:1090.
15. Braunschweig F, Kjellstrom B, Soderhall M, Clyne N, Linde C. Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor. Nephrol Dial Transplant. 2006;21:176-83.
16. Atar I, Konas D, Acikel S, Kulah E, Atar A, Bozbas H, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol. 2006;106:47-51.
17. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol. 2000;54:234-9.
18. Vázquez E, Sánchez-Perales C, Borrego F, García-Cortés MJ, Lozano C, Guzman M, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000;140:886-90.
19. Vázquez E, Sánchez-Perales C, Lozano C, García-Cortes MJ, Borrego F, Guzman M, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol. 2003;92:868-71.
20. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel B, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham Study. Circulation. 1998;98:946-52.
21. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
22. Wiesholzer M, Hann F, Tomasec G, Barbieri G, Putz D, Balcke P. Incidence of stroke among chronic hemodialysis patients with non-rheumatic atrial fibrillation. Am J Nephrol. 2001;121:35-9.
23. Heras M, Fernández-Ortiz A, Gómez-Guindal JA, Iriarte JA, Lidón RM, Pérez-Gómez F, et al. Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología. Rev Esp Cardiol. 1999:52:801-20.
24. Vázquez E, Sánchez-Perales C, García-Cortes MJ, Borrego F, Lozano C, Guzman M, et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Intern J Cardiol. 2003;87:135-9.
25. Fuster V. Aproximación terapéutica a la epidemia de fibrillación auricular. Rev Esp Cardiol. 2002;55:27-32.